Oxidative stress and neurodegeneration: where are we now?

PubWeight™: 5.44‹?› | Rank: Top 1%

🔗 View Article (PMID 16805774)

Published in J Neurochem on June 01, 2006

Authors

Barry Halliwell1

Author Affiliations

1: Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Articles citing this

(truncated to the top 100)

Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci (2008) 4.04

Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol (2007) 2.71

The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal (2009) 2.49

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol (2007) 2.36

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36

The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta (2007) 2.09

Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med (2009) 1.94

Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J (2007) 1.93

Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcohol Clin Exp Res (2011) 1.79

Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev (2012) 1.76

Redox control of the cell cycle in health and disease. Antioxid Redox Signal (2009) 1.72

Physiological, biochemical, and molecular mechanisms of heat stress tolerance in plants. Int J Mol Sci (2013) 1.71

Exogenous antioxidants-Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev (2016) 1.71

Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol (2009) 1.68

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity. Acta Psychiatr Scand (2014) 1.65

The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci (2009) 1.64

Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. Proc Natl Acad Sci U S A (2013) 1.61

Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection. J Neurosci (2008) 1.61

Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int (2014) 1.57

Exposure to diesel exhaust induces changes in EEG in human volunteers. Part Fibre Toxicol (2008) 1.54

Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans (2009) 1.50

Suppression of the intrinsic apoptosis pathway by synaptic activity. J Neurosci (2010) 1.40

Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem (2007) 1.40

Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev (2010) 1.30

Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid Redox Signal (2014) 1.29

Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease. Dalton Trans (2009) 1.29

Correlating neurobehavioral performance with biomarkers of organophosphorous pesticide exposure. Neurotoxicology (2010) 1.28

Recent advances in our understanding of neurodegeneration. J Neural Transm (Vienna) (2009) 1.27

System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol (2012) 1.27

Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int (2013) 1.25

Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathways. J Neuroinflammation (2010) 1.24

Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal (2012) 1.24

Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mech Ageing Dev (2013) 1.24

Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS One (2010) 1.22

Voltammetric detection of hydrogen peroxide at carbon fiber microelectrodes. Anal Chem (2010) 1.21

The CREB/CRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death. J Neurochem (2009) 1.21

Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. Channels (Austin) (2009) 1.21

Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev (2012) 1.21

Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons. Proc Natl Acad Sci U S A (2009) 1.20

Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18

Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases. J Neurochem (2008) 1.17

The Role of Oxidative Stress in Neurodegenerative Diseases. Exp Neurobiol (2015) 1.16

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. Biochim Biophys Acta (2011) 1.16

Smoking and increased Alzheimer's disease risk: a review of potential mechanisms. Alzheimers Dement (2014) 1.15

Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol (2007) 1.14

Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol (2008) 1.13

The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov (2012) 1.13

Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med (2010) 1.13

The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons. Eur J Neurosci (2008) 1.13

A delicate balance: Iron metabolism and diseases of the brain. Front Aging Neurosci (2013) 1.11

Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol Dis (2009) 1.11

Botanical phenolics and brain health. Neuromolecular Med (2008) 1.11

Reactive oxygen species and the brain in sleep apnea. Respir Physiol Neurobiol (2010) 1.10

ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev (2013) 1.09

Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Pharmacol Ther (2007) 1.09

Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol (2009) 1.09

Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev (2012) 1.08

Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia. Free Radic Biol Med (2007) 1.08

Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim Biophys Acta (2014) 1.08

Calpain and PARP activation during photoreceptor cell death in P23H and S334ter rhodopsin mutant rats. PLoS One (2011) 1.08

Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide. J Inorg Biochem (2008) 1.07

Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains. DNA Repair (Amst) (2008) 1.07

Iron and neurodegeneration in multiple sclerosis. Mult Scler Int (2011) 1.07

Ascorbic acid attenuates scopolamine-induced spatial learning deficits in the water maze. Behav Brain Res (2009) 1.07

Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J Cereb Blood Flow Metab (2008) 1.06

Mitochondrial protection attenuates inflammation-induced impairment of neurogenesis in vitro and in vivo. J Neurosci (2010) 1.06

Complexity of dopamine metabolism. Cell Commun Signal (2013) 1.06

Relationship of electrophilic stress to aging. Free Radic Biol Med (2011) 1.06

Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol (2011) 1.05

Potential contribution of oxidative stress and inflammation to anxiety and hypertension. Brain Res (2011) 1.05

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal (2010) 1.04

Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm (Vienna) (2012) 1.04

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry (2011) 1.03

Protective Effect of Safranal, a Constituent of Crocus sativus, on Quinolinic Acid-induced Oxidative Damage in Rat Hippocampus. Iran J Basic Med Sci (2013) 1.03

Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons. J Neurosci (2014) 1.03

The antioxidant paradox: less paradoxical now? Br J Clin Pharmacol (2013) 1.03

Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum. PLoS One (2009) 1.02

Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1. PLoS One (2013) 1.02

Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab (2011) 1.01

Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev (2012) 1.01

Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons Dis (2011) 1.00

Neuroprotection in the newborn infant. Clin Perinatol (2009) 0.99

The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2. PLoS One (2013) 0.99

Nuclear transport: a switch for the oxidative stress-signaling circuit? J Signal Transduct (2011) 0.98

Omega-3 and omega-6 fatty acids suppress ER- and oxidative stress in cultured neurons and neuronal progenitor cells from mice lacking PPT1. Neurosci Lett (2010) 0.98

Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine. J Neurochem (2008) 0.98

NURR1 in Parkinson disease--from pathogenesis to therapeutic potential. Nat Rev Neurol (2013) 0.98

Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. J Neurochem (2010) 0.97

Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol (2013) 0.97

Synaptosomal toxicity and nucleophilic targets of 4-hydroxy-2-nonenal. Toxicol Sci (2008) 0.97

E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity. J Cell Biol (2008) 0.97

3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci (2009) 0.97

Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia. J Neurosci (2010) 0.97

Regional siderosis: a new challenge for iron chelation therapy. Front Pharmacol (2013) 0.96

Oxidative stress in schizophrenia. Curr Neuropharmacol (2011) 0.96

Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF? Br J Pharmacol (2014) 0.96

Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats. Cell J (2015) 0.96

Mitochondria and energetic depression in cell pathophysiology. Int J Mol Sci (2009) 0.95

Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis. J Neurosci Res (2010) 0.95

A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genet (2007) 0.95

Articles by these authors

Approaches for extending human healthspan: from antioxidants to healthspan pharmacology. Essays Biochem (2017) 0.75